| 000 | 04629naa a22005897i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-043 | ||
| 003 | local | ||
| 005 | 20261005174904.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2016 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.3389/fcvm.2016.00021 _2doi |
|
| 035 | _a(local)EuropePMC:PMC4954824 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aMarta Gigli _eauthor. |
|
| 245 | 1 | 2 |
_aA Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies. / _cMarta Gigli; Rene L Begay; Gaetano Morea [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bFrontiers Media SA, _c2016. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aTitin (TTN) is known as the largest sarcomeric protein that resides within the heart muscle. Due to alternative splicing of TTN, the heart expresses two major isoforms (N2B and N2BA) that incorporate four distinct regions termed the Z-line, I-band, A-band, and M-line. Next-generation sequencing allows a large number of genes to be sequenced simultaneously and provides the opportunity to easily analyze giant genes such as TTN. Mutations in the TTN gene can cause cardiomyopathies, in particular dilated cardiomyopathy (DCM). DCM is the most common form of cardiomyopathy, and it is characterized by systolic dysfunction and dilation of the left ventricle. TTN truncating variants have been described as the most common cause of DCM, while the real impact of TTN missense variants in the pathogenesis of DCM is still unclear. In a recent population screening study, rare missense variants potentially pathogenic based on bioinformatic filtering represented only 12.6% of the several hundred rare TTN missense variants found, suggesting that missense variants are very common in TTN and are frequently benign. The aim of this review is to understand the clinical role of TTN mutations in DCM and in other cardiomyopathies. Whereas TTN truncations are common in DCM, there is evidence that TTN truncations are rare in the hypertrophic cardiomyopathy (HCM) phenotype. Furthermore, TTN mutations can also cause arrhythmogenic right ventricular cardiomyopathy (ARVC) with distinct clinical features and outcomes. Finally, the identification of a rare TTN missense variant cosegregating with the restrictive cardiomyopathy (RCM) phenotype suggests that TTN is a novel disease-causing gene in this disease. Clinical diagnostic testing is currently able to analyze over 100 cardiomyopathy genes, including TTN; however, the size and presence of extensive genetic variation in TTN presents clinical challenges in determining significant disease-causing mutations. This review discusses the current knowledge of TTN genetic variations in cardiomyopathies and the impact of the diagnosis of TTN pathogenic mutations in the clinical setting. | |
| 540 |
_aCreative Commons Attribution. See the linked licence for the applicable terms. _uhttp://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aHeart Failure | |
| 650 | 4 | _aClinical Diagnosis | |
| 650 | 4 | _aClinical Genetics | |
| 650 | 4 | _aCardiovascular Genetics | |
| 650 | 4 | _aFamilial Cardiomyopathy | |
| 650 | 4 | _aTitin | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _amolecular diagnostics | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aRene L Begay _eauthor. |
|
| 700 | 0 |
_aGaetano Morea _eauthor. |
|
| 700 | 0 |
_aSharon L Graw _eauthor. |
|
| 700 | 0 |
_aGianfranco Sinagra _eauthor. |
|
| 700 | 0 |
_aMatthew R G Taylor _eauthor. |
|
| 700 | 0 |
_aHenk Granzier _eauthor. |
|
| 700 | 0 |
_aLuisa Mestroni _eauthor. |
|
| 773 | 0 |
_tFrontiers in cardiovascular medicine _gVol. 3, (2016), pages/article 21 _x2297-055X |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC4954824 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC4954824 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1185 _d1185 |
||